Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT04936009
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Accepted

Interventions

  • Transcranial Magnetic Stimulation (TMS) — BEHAVIORAL
    Subjects will receive both active and sham TMS in a randomized crossover assignment involving two study sessions

Study Details

This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).

Key Dates

Start date
Mar 17, 2022
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Jul 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: Transcranial Magnetic Stimulation - real
    Participants will receive active TMS during their study visit
  • Placebo Comparator: Transcranial Magnetic Stimulation - sham
    Participants will receive sham stimulation during their study visit simulating TMS

Primary Outcome Measure

right hemisphere N170 latency [ Time Frame: Measures will be recorded during the EEG/ET sessions of participant visits for an expected 1-2 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Yale University Child Study CenterNew HavenConnecticut06520
Nicole Wright
860-785-3488
Adam Naples, PhD (SUB_INVESTIGATOR)
James McPartland, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Haven, CT

By specialty

Related Studies